Riyadh: The Saudi National Institute of Health signed a memorandum of understanding (MoU) with French pharmaceutical company Sanofi on the sidelines of the Saudi-French Investment Forum in Paris.

According to Saudi Press Agency, the MoU aims to enhance cooperation in research and development, innovation, and clinical research. It seeks to develop public-private partnerships to support the development of promising therapeutic solutions and health technologies. The agreement is designed to strengthen the health research and innovation ecosystem and to build research capabilities in line with the objectives of the Health Sector Transformation Program under Saudi Vision 2030.

The MoU builds on the longstanding relations between Saudi Arabia and France and reflects both sides' commitment to exchanging expertise. It aims to develop high-impact partnerships that support clinical research, advance innovation, and translate research outputs into innovative and sustainable healthcare solutions that serve human health.